The performance of the Low-Profile Visualized Intraluminal Support (LVIS) stent deployed following balloon angioplasty is unknown in treating intracranial atherosclerotic stenosis, and this study was to investigate the safety and efficacy of the LVIS stent in treating intracranial atherosclerotic stenosis in the middle cerebral artery M1 segment.
Methods
Thirty-five patients were enrolled with 35 atherosclerotic stenoses at the M1 segment. The stenosis was about 75% in 16 patients, 80% in 15, and 90% in the rest four. The LVIS stent was used to treat these patients.
Results
The success rate of stenting was 97.1%. The stenting procedure was failed in one patient because of intraprocedural dissection of the stenotic (75%) segment, resulting in a 30-day periprocedural complication rate of 2.9% (1/35). Before stenting, the stenosis rate ranged 75%–90% (mean 78.9% ± 4.7%), and after stenting, the diameter of the stented segment was significantly (P < 0.0001) increased to 1.5–3.4 mm (mean 2.1 ± 0.32 mm) ranging 68.2%–100% (mean 94.0% ± 5.8%) of the normal arterial diameter, with the residual stenosis ranging 0–31.8% (median 4.8%, IQR 2.4%–7.3%). Follow-up was performed at 6–20 months (mean 8.5) after stenting. One patient (2.9%) had occlusion of the stented M1 segment with no symptoms, and two patients (5.7%) had slight asymptomatic instent stenosis (40%) at the M1 segment, with the instent restenosis and occlusion rate of 8.6% (3/35).
Conclusion
The braided LVIS stent can be safely applied for treatment of intracranial atherosclerotic stenosis in the middle cerebral artery with good safety and efficacy immediately after stenting and at follow-up.
{"title":"Safety and efficacy of the Low-Profile Visualized Intraluminal Support stent in treating intracranial atherosclerotic stenosis","authors":"J.-W. Wang, X.-Y. Li, C.-H. Li, J.-F. Liu, H. Li, Y.-Y. Tian, B.-L. Gao","doi":"10.1016/j.nrl.2021.02.013","DOIUrl":"10.1016/j.nrl.2021.02.013","url":null,"abstract":"<div><h3>Purpose</h3><p>The performance of the Low-Profile Visualized Intraluminal Support (LVIS) stent deployed following balloon angioplasty is unknown in treating intracranial atherosclerotic stenosis, and this study was to investigate the safety and efficacy of the LVIS stent in treating intracranial atherosclerotic stenosis in the middle cerebral artery M1 segment.</p></div><div><h3>Methods</h3><p>Thirty-five patients were enrolled with 35 atherosclerotic stenoses at the M1 segment. The stenosis was about 75% in 16 patients, 80% in 15, and 90% in the rest four. The LVIS stent was used to treat these patients.</p></div><div><h3>Results</h3><p>The success rate of stenting was 97.1%. The stenting procedure was failed in one patient because of intraprocedural dissection of the stenotic (75%) segment, resulting in a 30-day periprocedural complication rate of 2.9% (1/35). Before stenting, the stenosis rate ranged 75%–90% (mean 78.9%<!--> <!-->±<!--> <!-->4.7%), and after stenting, the diameter of the stented segment was significantly (<em>P</em> <!--><<!--> <!-->0.0001) increased to 1.5–3.4<!--> <!-->mm (mean 2.1<!--> <!-->±<!--> <!-->0.32<!--> <!-->mm) ranging 68.2%–100% (mean 94.0%<!--> <!-->±<!--> <!-->5.8%) of the normal arterial diameter, with the residual stenosis ranging 0–31.8% (median 4.8%, IQR 2.4%–7.3%). Follow-up was performed at 6–20 months (mean 8.5) after stenting. One patient (2.9%) had occlusion of the stented M1 segment with no symptoms, and two patients (5.7%) had slight asymptomatic instent stenosis (40%) at the M1 segment, with the instent restenosis and occlusion rate of 8.6% (3/35).</p></div><div><h3>Conclusion</h3><p>The braided LVIS stent can be safely applied for treatment of intracranial atherosclerotic stenosis in the middle cerebral artery with good safety and efficacy immediately after stenting and at follow-up.</p></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 8","pages":"Pages 521-529"},"PeriodicalIF":3.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.nrl.2021.02.013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38906922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.1016/j.nrl.2020.10.017
M. Vázquez-Marrufo , E. Sarrias-Arrabal , M. García-Torres , R. Martín-Clemente , G. Izquierdo
Introduction
The applications of artificial intelligence, and in particular automatic learning or “machine learning” (ML), constitute both a challenge and a great opportunity in numerous scientific, technical, and clinical disciplines. Specific applications in the study of multiple sclerosis (MS) have been no exception, and constitute an area of increasing interest in recent years.
Objective
We present a systematic review of the application of ML algorithms in MS.
Materials and methods
We used the PubMed search engine, which allows free access to the MEDLINE medical database, to identify studies including the keywords “machine learning” and “multiple sclerosis.” We excluded review articles, studies written in languages other than English or Spanish, and studies that were mainly technical and did not specifically apply to MS. The final selection included 76 articles, and 38 were rejected.
Conclusions
After the review process, we established 4 main applications of ML in MS: 1) classifying MS subtypes; 2) distinguishing patients with MS from healthy controls and individuals with other diseases; 3) predicting progression and response to therapeutic interventions; and 4) other applications. Results found to date have shown that ML algorithms may offer great support for health professionals both in clinical settings and in research into MS.
{"title":"Revisión sistemática de la aplicación de algoritmos de «machine learning» en la esclerosis múltiple","authors":"M. Vázquez-Marrufo , E. Sarrias-Arrabal , M. García-Torres , R. Martín-Clemente , G. Izquierdo","doi":"10.1016/j.nrl.2020.10.017","DOIUrl":"https://doi.org/10.1016/j.nrl.2020.10.017","url":null,"abstract":"<div><h3>Introduction</h3><p>The applications of artificial intelligence, and in particular automatic learning or “machine learning” (ML), constitute both a challenge and a great opportunity in numerous scientific, technical, and clinical disciplines. Specific applications in the study of multiple sclerosis (MS) have been no exception, and constitute an area of increasing interest in recent years.</p></div><div><h3>Objective</h3><p>We present a systematic review of the application of ML algorithms in MS.</p></div><div><h3>Materials and methods</h3><p>We used the PubMed search engine, which allows free access to the MEDLINE medical database, to identify studies including the keywords “machine learning” and “multiple sclerosis.” We excluded review articles, studies written in languages other than English or Spanish, and studies that were mainly technical and did not specifically apply to MS. The final selection included 76 articles, and 38 were rejected.</p></div><div><h3>Conclusions</h3><p>After the review process, we established 4 main applications of ML in MS: 1) classifying MS subtypes; 2) distinguishing patients with MS from healthy controls and individuals with other diseases; 3) predicting progression and response to therapeutic interventions; and 4) other applications. Results found to date have shown that ML algorithms may offer great support for health professionals both in clinical settings and in research into MS.</p></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 8","pages":"Pages 577-590"},"PeriodicalIF":3.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.nrl.2020.10.017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50190507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.1016/j.nrl.2021.02.006
M. Torres-Ferrus , A.C. López-Veloso , V. Gonzalez-Quintanilla , N. González-García , J. Díaz de Teran , A. Gago-Veiga , J. Camiña , M. Ruiz , N. Mas-Sala , S. Bohórquez , V.J. Gallardo , P. Pozo-Rosich
Background
Migraine attacks have a high impact on daily activities. There is limited research on the burden of migraine on sexual functioning.
Objective
To determine the prevalence of sexual dysfunction in patients with migraine and its relationship with migraine features and comorbidities.
Method
This is a cross-sectional study. We included migraine patients between 18 and 60 years-old from 8 Headache Clinics in Spain. We recorded demographic data and migraine features. Patients fulfilled a survey including comorbidities, Arizona Sexual Experiences Scale, Hospital Anxiety and Depression Scale and a questionnaire about migraine impact on sexual activity. A K-nearest neighbor supervised learning algorithm was used to identify differences between migraine patients with and without sexual dysfunction.
Results
We included 306 patients (85.6% women, mean age 42.3 ±11.1 years). A 41.8% of participants had sexual dysfunction. Sexual dysfunction was associated with being female (OR [95% CI]: 2.42 [1.17–5.00]; p < 0.001), being older than 46.5 years (4.04 [2.48–6.59]; p < 0.001), having chronic migraine (2.31 [1.41–3.77]; p = 0.001), using preventive medication (2.45 [1.35–4.45]; p = 0.004), analgesic overusing (3.51 [2.03–6.07]; p < 0.001), menopause (4.18 [2.43–7.17]; p < 0.001) and anxiety (2.90 [1.80–4.67]; p < 0.001) and depression (6.14 [3.18–11.83]; p < 0.001). However, only female gender, age, menopause and depression were the statistically significant variables selected in the model to classify migraine patients with or without sexual dysfunction (Accuracy [95% CI]: 0.75 (0.62–0.85), Kappa: 0.48, p = 0.005).
Conclusions
Sexual dysfunction is frequent in migraine patients visited in a headache clinic. However, migraine characteristics or use of preventive medication are not directly associated with sexual dysfunction. Instead, risk factors for sexual dysfunction were female gender, higher age, menopause and depression.
{"title":"The MIGREX study: Prevalence and risk factors of sexual dysfunction among migraine patients","authors":"M. Torres-Ferrus , A.C. López-Veloso , V. Gonzalez-Quintanilla , N. González-García , J. Díaz de Teran , A. Gago-Veiga , J. Camiña , M. Ruiz , N. Mas-Sala , S. Bohórquez , V.J. Gallardo , P. Pozo-Rosich","doi":"10.1016/j.nrl.2021.02.006","DOIUrl":"10.1016/j.nrl.2021.02.006","url":null,"abstract":"<div><h3>Background</h3><p>Migraine attacks have a high impact on daily activities. There is limited research on the burden of migraine on sexual functioning.</p></div><div><h3>Objective</h3><p>To determine the prevalence of sexual dysfunction in patients with migraine and its relationship with migraine features and comorbidities.</p></div><div><h3>Method</h3><p>This is a cross-sectional study. We included migraine patients between 18 and 60 years-old from 8 Headache Clinics in Spain. We recorded demographic data and migraine features. Patients fulfilled a survey including comorbidities, Arizona Sexual Experiences Scale, Hospital Anxiety and Depression Scale and a questionnaire about migraine impact on sexual activity. A K-nearest neighbor supervised learning algorithm was used to identify differences between migraine patients with and without sexual dysfunction.</p></div><div><h3>Results</h3><p>We included 306 patients (85.6% women, mean age 42.3<!--> <!-->±11.1 years). A 41.8% of participants had sexual dysfunction. Sexual dysfunction was associated with being female (OR [95% CI]: 2.42 [1.17–5.00]; <em>p</em> <!--><<!--> <!-->0.001), being older than 46.5 years (4.04 [2.48–6.59]; <em>p</em> <!--><<!--> <!-->0.001), having chronic migraine (2.31 [1.41–3.77]; <em>p</em> <!-->=<!--> <!-->0.001), using preventive medication (2.45 [1.35–4.45]; <em>p</em> <!-->=<!--> <!-->0.004), analgesic overusing (3.51 [2.03–6.07]; <em>p</em> <!--><<!--> <!-->0.001), menopause (4.18 [2.43–7.17]; <em>p</em> <!--><<!--> <!-->0.001) and anxiety (2.90 [1.80–4.67]; <em>p</em> <!--><<!--> <!-->0.001) and depression (6.14 [3.18–11.83]; <em>p</em> <!--><<!--> <!-->0.001). However, only female gender, age, menopause and depression were the statistically significant variables selected in the model to classify migraine patients with or without sexual dysfunction (Accuracy [95% CI]: 0.75 (0.62–0.85), Kappa: 0.48, <em>p</em> <!-->=<!--> <!-->0.005).</p></div><div><h3>Conclusions</h3><p>Sexual dysfunction is frequent in migraine patients visited in a headache clinic. However, migraine characteristics or use of preventive medication are not directly associated with sexual dysfunction. Instead, risk factors for sexual dysfunction were female gender, higher age, menopause and depression.</p></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 8","pages":"Pages 541-549"},"PeriodicalIF":3.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.nrl.2021.02.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25518477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.1016/j.nrl.2022.09.006
M. Viscasillas Sancho, C. Moreno Loscertales, S. García Rubio, D. Sagarra Mur
{"title":"Encefalopatía de Hashimoto posvacuna frente a coronavirus 2 del síndrome respiratorio agudo grave","authors":"M. Viscasillas Sancho, C. Moreno Loscertales, S. García Rubio, D. Sagarra Mur","doi":"10.1016/j.nrl.2022.09.006","DOIUrl":"https://doi.org/10.1016/j.nrl.2022.09.006","url":null,"abstract":"","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 8","pages":"Pages 601-602"},"PeriodicalIF":3.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50169050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.1016/j.nrl.2020.10.015
R. López-Blanco , A. Sorrentino Rodriguez , E. Cubo , Í. Gabilondo , D. Ezpeleta , M.A. Labrador-Espinosa , Á. Sánchez-Ferro , C. Tejero , M. Matarazzo , por el Comité Ad-Hoc de Nuevas Tecnologías de la SEN
Introduction
New technologies (NT) are increasingly widespread in biomedicine. Using the consensus definition of NT established by the New Technologies Ad-Hoc Committee of the Spanish Society of Neurology (SEN), we evaluated the impact of these technologies on Spanish neurology, based on communications presented at Annual Meetings of the SEN.
Material and methods
We defined the concept of NT in neurology as a novel technology or novel application of an existing technology, characterised by a certain degree of coherence persisting over time, with the potential to have an impact on the present and/or future of neurology. We conducted a descriptive study of scientific communications presented at the SEN's annual meetings from 2012 to 2018, analysing the type of NT, the field of neurology, and the geographical provenance of the studies.
Results
We identified 299 communications related with NT from a total of 8,139 (3.7%), including 120 posters and 179 oral communications, ranging from 1.6% of all communications in 2012 to 6.8% in 2018. The technologies most commonly addressed were advanced neuroimaging (24.7%), biosensors (17.1%), electrophysiology and neurostimulation (14.7%), and telemedicine (13.7%). The neurological fields where NT were most widely employed were movement disorders (18.4%), cerebrovascular diseases (15.7%), and dementia (13.4%). Madrid was the region presenting the highest number of communications related to NT (32.8%), followed by Catalonia (26.8%) and Andalusia (9.0%).
Conclusions
The number of communications addressing NT follows an upward trend. The number of NT used in neurology has increased in parallel with their availability. We found scientific communications in all neurological subspecialties, with a heterogeneous geographical distribution.
{"title":"Impacto de las nuevas tecnologías en la neurología en España. Revisión del Comité Ad-Hoc de Nuevas Tecnologías de la Sociedad Española de Neurología","authors":"R. López-Blanco , A. Sorrentino Rodriguez , E. Cubo , Í. Gabilondo , D. Ezpeleta , M.A. Labrador-Espinosa , Á. Sánchez-Ferro , C. Tejero , M. Matarazzo , por el Comité Ad-Hoc de Nuevas Tecnologías de la SEN","doi":"10.1016/j.nrl.2020.10.015","DOIUrl":"https://doi.org/10.1016/j.nrl.2020.10.015","url":null,"abstract":"<div><h3>Introduction</h3><p>New technologies (NT) are increasingly widespread in biomedicine. Using the consensus definition of NT established by the New Technologies Ad-Hoc Committee of the Spanish Society of Neurology (SEN), we evaluated the impact of these technologies on Spanish neurology, based on communications presented at Annual Meetings of the SEN.</p></div><div><h3>Material and methods</h3><p>We defined the concept of NT in neurology as a novel technology or novel application of an existing technology, characterised by a certain degree of coherence persisting over time, with the potential to have an impact on the present and/or future of neurology. We conducted a descriptive study of scientific communications presented at the SEN's annual meetings from 2012 to 2018, analysing the type of NT, the field of neurology, and the geographical provenance of the studies.</p></div><div><h3>Results</h3><p>We identified 299 communications related with NT from a total of 8,139 (3.7%), including 120 posters and 179 oral communications, ranging from 1.6% of all communications in 2012 to 6.8% in 2018. The technologies most commonly addressed were advanced neuroimaging (24.7%), biosensors (17.1%), electrophysiology and neurostimulation (14.7%), and telemedicine (13.7%). The neurological fields where NT were most widely employed were movement disorders (18.4%), cerebrovascular diseases (15.7%), and dementia (13.4%). Madrid was the region presenting the highest number of communications related to NT (32.8%), followed by Catalonia (26.8%) and Andalusia (9.0%).</p></div><div><h3>Conclusions</h3><p>The number of communications addressing NT follows an upward trend. The number of NT used in neurology has increased in parallel with their availability. We found scientific communications in all neurological subspecialties, with a heterogeneous geographical distribution.</p></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 8","pages":"Pages 591-598"},"PeriodicalIF":3.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.nrl.2020.10.015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50190508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1016/j.nrl.2021.01.009
A.R. Bentivoglio , M.R. Lo Monaco , R. Liperoti , D. Fusco , E. Di Stasio , A. Tondinelli , D. Marzullo , A. Maino , M.C. Cipriani , M.C. Silveri
Background
and Sex and cognitive profile may be related to the laterality of motor symptoms in idiopathic Parkinson's disease.
Introduction
Parkinson's disease (PD) is well recognised as an inherently asymmetric disease with unilateral onset of motor symptoms. The laterality of motor symptoms may be linked to sex, clinical and demographic variables, and neuropsychological disorders. However, the available data are inconsistent. This study aimed to explore the potential association between the laterality of motor symptoms and clinical and demographic variables and deficits in specific cognitive domains.
Material and methods
We retrospectively recruited 97 participants with idiopathic PD without dementia; 60 presented motor symptoms on the left side and 37 on the right side. Both groups were comparable in terms of age, age at disease onset, disease duration, and severity of the neurological deficits according to the Unified Parkinson's Disease Rating Scale and the Hoehn and Yahr scale.
Results
Participants with left-side motor symptoms scored lower on the Schwab and England Activities of Daily Living scale. Our sample included more men than women (67% vs. 33%). Both sexes were not equally represented in the 2 groups: there were significantly more men than women in the group of patients with left-side motor symptoms (77% vs. 23%), whereas the percentages of men and women in the group of patients with right-side motor symptoms were similar (51% vs. 49%). Both groups performed similarly in all neuropsychological tasks, but women, independently of laterality, performed better than men in the naming task.
Conclusion
We found a clear prevalence of men in the group of patients with left-side motor symptoms; this group also scored lower on the Schwab and England Scale. Female sex was predictive of better performance in the naming task. Sex should always be considered in disorders that cause asymmetric involvement of the brain, such as PD.
{"title":"Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease","authors":"A.R. Bentivoglio , M.R. Lo Monaco , R. Liperoti , D. Fusco , E. Di Stasio , A. Tondinelli , D. Marzullo , A. Maino , M.C. Cipriani , M.C. Silveri","doi":"10.1016/j.nrl.2021.01.009","DOIUrl":"10.1016/j.nrl.2021.01.009","url":null,"abstract":"<div><h3>Background</h3><p>and Sex and cognitive profile may be related to the laterality of motor symptoms in idiopathic Parkinson's disease.</p></div><div><h3>Introduction</h3><p>Parkinson's disease (PD) is well recognised as an inherently asymmetric disease with unilateral onset of motor symptoms. The laterality of motor symptoms may be linked to sex, clinical and demographic variables, and neuropsychological disorders. However, the available data are inconsistent. This study aimed to explore the potential association between the laterality of motor symptoms and clinical and demographic variables and deficits in specific cognitive domains.</p></div><div><h3>Material and methods</h3><p>We retrospectively recruited 97 participants with idiopathic PD without dementia; 60 presented motor symptoms on the left side and 37 on the right side. Both groups were comparable in terms of age, age at disease onset, disease duration, and severity of the neurological deficits according to the Unified Parkinson's Disease Rating Scale and the Hoehn and Yahr scale.</p></div><div><h3>Results</h3><p>Participants with left-side motor symptoms scored lower on the Schwab and England Activities of Daily Living scale. Our sample included more men than women (67% vs. 33%). Both sexes were not equally represented in the 2 groups: there were significantly more men than women in the group of patients with left-side motor symptoms (77% vs. 23%), whereas the percentages of men and women in the group of patients with right-side motor symptoms were similar (51% vs. 49%). Both groups performed similarly in all neuropsychological tasks, but women, independently of laterality, performed better than men in the naming task.</p></div><div><h3>Conclusion</h3><p>We found a clear prevalence of men in the group of patients with left-side motor symptoms; this group also scored lower on the Schwab and England Scale. Female sex was predictive of better performance in the naming task. Sex should always be considered in disorders that cause asymmetric involvement of the brain, such as PD.</p></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 7","pages":"Pages 467-474"},"PeriodicalIF":3.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.nrl.2021.01.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25494752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1016/j.nrl.2022.08.003
M. Mendibe Bilbao , D. Ezpeleta Echávarri , J.M. Láinez Andrés
{"title":"La SEN y el modelo español de recertificación impulsado por FACME y sus sociedades científico-médicas federadas","authors":"M. Mendibe Bilbao , D. Ezpeleta Echávarri , J.M. Láinez Andrés","doi":"10.1016/j.nrl.2022.08.003","DOIUrl":"10.1016/j.nrl.2022.08.003","url":null,"abstract":"","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 7","pages":"Pages 519-520"},"PeriodicalIF":3.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42718081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1016/j.nrl.2022.08.002
A. Sanchez-Larsen, L. Rojas-Bartolomé, M. Fernández-Valiente, D. Sopelana
{"title":"Encefalitis anti-NMDA-R post-COVID-19: descripción de un caso y propuesta de su mecanismo fisiopatológico","authors":"A. Sanchez-Larsen, L. Rojas-Bartolomé, M. Fernández-Valiente, D. Sopelana","doi":"10.1016/j.nrl.2022.08.002","DOIUrl":"https://doi.org/10.1016/j.nrl.2022.08.002","url":null,"abstract":"","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 7","pages":"Pages 513-516"},"PeriodicalIF":3.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50180342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号